Target intelligence / Profile preview

Coenzyme Q10 (CoQ10) (CoQ10)

Target
CoQ10
Molecular classification
Electron carrier, Antioxidant, Cofactor, Lipid-soluble quinone
01

Overview

Coenzyme Q10 (CoQ10), also known as ubiquinone, is a vital lipophilic molecule located within the inner mitochondrial membrane where it functions as a mobile electron carrier in the electron transport chain (StatPearls, 2023). It facilitates the transfer of electrons from Complex I and Complex II to Complex III, a critical step in the generation of adenosine triphosphate (ATP) through oxidative phosphorylation (PubChem, CID 5281915). Beyond its role in bioenergetics, the CoQ10 pool acts as a potent lipid-soluble antioxidant, protecting mitochondrial membranes and lipoproteins from oxidative damage and playing a key role in the prevention of ferroptosis (Hernandez-Camacho et al., 2018). Deficiencies in the CoQ10 pool, whether primary (genetic) or secondary (due to aging or drugs like statins), are linked to mitochondrial diseases, heart failure, and neurodegenerative disorders (NIH Office of Dietary Supplements, 2020). Therapeutically, the CoQ10 pool is targeted through direct supplementation or synthetic analogs like idebenone to restore respiratory chain function and mitigate oxidative stress (Garrido-Maraver et al., 2014). However, clinical efficacy can be limited by its high hydrophobicity and poor oral bioavailability, leading to the development of mitochondria-targeted formulations like MitoQ (Smith et al., 2012).

Other names
UbiquinoneUbiquinolCoQQ10Vitamin Q10Mitochondrial CoQ10 pool
02

Mechanism of action

Restoration of electron flow in the mitochondrial respiratory chain, scavenging of reactive oxygen species (ROS), inhibition of lipid peroxidation, and maintenance of mitochondrial membrane potential.

03

Biological functions

Mitochondrial electron transportOxidative phosphorylationAntioxidant activityFerroptosis inhibitionRegulation of mitochondrial permeability transition pore
04

Disease associations

Primary Coenzyme Q10 deficiencyMitochondrial encephalomyopathyHeart failureParkinson's diseaseStatin-induced myopathy
05

Safety considerations

Interaction with Vitamin K antagonists (e.g., Warfarin)Poor oral bioavailabilityGastrointestinal distressPotential reduction in chemotherapy efficacy due to antioxidant properties
06

Interacting drugs

Coenzyme Q10 (Ubidecarenone)

5 more in the full profile.

07

Biomarkers

Plasma CoQ10 concentrationMuscle CoQ10 levelsFibroblast CoQ10 levelsLactate/pyruvate ratio

Beyond the preview

Go deeper on Coenzyme Q10 (CoQ10) (CoQ10).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Coenzyme Q10 (CoQ10) (CoQ10).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call